Big Pharma Split Corp.

TSX:PRM.TO

14.61 (CAD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CAD.

2023202220212020201920182017
Operating Activities:
Net Income -0.6452.3894.21-0.2172.582.105-0.318
Depreciation & Amortization 0000000
Deferred Income Tax 0000000
Stock Based Compensation 0000000
Change In Working Capital 0.010.175-0.154-0.032-0.003-0.0540.054
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables 0000000
Other Working Capital 0.010.175-0.154-0.032-0.003-0.0540.649
Other Non Cash Items 12.494-1.436-13.0564.5976.102-0.78-30.69
Operating Cash Flow 11.8581.128-94.3488.6791.271-30.954
Investing Activities:
Investments In Property Plant And Equipment 0000000
Acquisitions Net 0000000
Purchases Of Investments 0000000
Sales Maturities Of Investments 0000000
Other Investing Activites 0000000
Investing Cash Flow 0000000
Financing Activities:
Debt Repayment -5.485-0.481-5.747-1.234-2.82700
Common Stock Issued 0.4450.47.57400020.4
Common Stock Repurchased -10.80700-2.921-6.485-0.4560
Dividends Paid -1.54-1.866-2.218-1.233-1.484-2.2530
Other Financing Activities -5.040.4795.455-2.921-6.485-0.19112.335
Financing Cash Flow -12.471-1.73710.194-4.652-8.569-2.7132.735
Other Information:
Effect Of Forex Changes On Cash -0.003-0.0020.005-0.0010.0090.010.064
Net Change In Cash -0.615-0.6111.199-0.3050.119-1.4281.846
Cash At End Of Period 0.2040.8191.430.2310.5360.4171.846